Skip to Main Content

Paper Details

Inhibition of the angiotensin II type 2 receptor AT<sub>2</sub>R is a novel therapeutic strategy for glioblastoma.
Proc Natl Acad Sci U S A
3
2022
Author NameAffiliation
Gye Won HanBridge Institute, University of Southern California
  • 1 - 1

Datasets

Release 1.2